Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Long Beach, California


Purpose:

The study will evaluate the antipsychotic efficacy of ITI-007 in a randomized, double-blind, parallel-group, placebo- and active-controlled, multi-center study in patients diagnosed with schizophrenia having an acute exacerbation of psychosis.


Criteria:

Inclusion Criteria: - male or female subjects of any race, ages 18-60 inclusive, with a clinical diagnosis of schizophrenia - experiencing an acute exacerbation of psychosis Exclusion Criteria: - any subject unable to provide informed consent - any female subject who is pregnant or breast-feeding - any subject judged to be medically inappropriate for study participation


NCT ID:

NCT02469155


Primary Contact:

Study Director
Kimberly Vanover, Ph.D.
Intra-Cellular Therapies, Inc.


Backup Contact:

N/A


Location Contact:

Long Beach, California
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.